MENU
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atea Pharmaceuticals (AVIR) Ownership - Who owns Atea Pharmaceuticals?
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
295.25M
P/E Ratio
N/A
Total Cash
425.44M
Projected Growth
N/A
Total Debt
1.45M
Revenue
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
4.97
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVIR
Capitalization
295M
P/E Ratio
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
425M
Total Cash/Share
4.97
Total Debt
1.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
411M
P/B Ratio
0.72
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
19.94
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-161.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.09
Shares Held By Institutions
248M
Shares Outstanding - Current
85.6M
Total Liabilities
28.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
2.985
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of vaccines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com